Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 5, 2025Regenerative BiomaterialsOpen Access

Exosome-based Sfrp2 inhibition in mesangial cells alleviates osteoporosis and promotes osteointegration in diabetic kidney disease

View Full Paper
Ask AI
Bookmark
Share

Authors

HXHelin XingYLYang LiuMQMeihua Qu

Discussion

Loading...

Member takes

Overview

Observational analysis reveals Sfrp2’s role in promoting osteointegration and combating osteoporosis in diabetic kidney disease.

Key Points

  • Exosome-mediated silencing of Sfrp2 alleviates osteoporosis in diabetic kidney disease models.
  • Elevated Sfrp2 in kidney mesangial cells suppresses Wnt signaling, contributing to bone loss.
  • Delivery of siSfrp2 via exosomes restored Wnt signaling, improving bone health in diabetic mice.
  • Significant enhancement of implant osseointegration is observed following Sfrp2 knockdown in diabetic rats.

Cite This Study

Xing et al. (2025) studied this question.

synapsesocial.com/papers/68bb5f266d6d5674bcd0320chttps://doi.org/10.1093/rb/rbaf093
View Full Paper
Ask AI
Bookmark
Share